Measles Virus IgG

Qualititative chemiluminescent immuno-assay (CLIA) for Measles virus IgG antibody testing. Used to determine measles susceptibility in pregnant women and immunocompromised individuals following possible measles exposure, or to assess need for MMR vaccine in health care workers and other vaccine candidates. This assay is available routinely Mon to Fri. Please Note: This test has not yet been assessed by UKAS for ISO15189: 2012 compliance.

Clinical details: 
- Post possible measles exposure to assess susceptibility and need for post-exposure prophylaxis. For individiuals at risk of severe measles - pregnant; immunocompromised - and without a reliable history of vaccination.
- Assess need for MMR vaccine in health care workers and other vaccine candidates.
Reference range: 

Not applicable

Synonyms or keywords: 
Measles Pregnancy Immunocompromised host MMR health care workers
Qualitative - Detected/Not Detected
Sample type and Volume required: 
2.5 – 5ml Yellow Top Serum Separation Tube (SST) Clotted Blood (for serum).
Turnaround time: 
7 days
Storage and transport: 
Place labelled sample in a sealed sample bag and send to Central Specimen Reception (CSR). To prevent sample haemolysis please store samples in refrigerator if a delay in sending samples to CSR is unavoidable.
Infection Sciences Department at St Thomas' Hospital
020 7188 8008
St Thomas' Hospital
North Wing - 5th Floor
Westminster Bridge Road
London SE1 7EH
Core opening hours: Monday-Friday 0900-1730

For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 28/11/2018